A Preliminary Study Conducted on a Traditional Formulation used for the Treatment of Dengue
Date
2022Author
Handagala, JK
Kumarasinghe, NP
Goonasekara, CL
Kuruppu, AI
Metadata
Show full item recordAbstract
Currently, around the globe, there are no effective drugs for the treatment of acute dengue
infection. Even though a vaccine was licensed recently, it was found to have limited efficacy.
Scientists are currently seeking for a novel treatment for dengue. Bamboo Swarasa is a Sri Lankan
traditional medicinal preparation made from shoots of yellow and green common bamboo
(Bambusa vulgaris) extracts together with Palmyra sugar. This preparation is currently given to
patients with dengue fever. Initially, we assessed the phenolic, flavonoid and antioxidant content
of this preparation by Total Phenolic Content (TPC), Total Flavonoid Content (TFC), 1,1-diphenyl-
2-picrylhydrazyl assay (DPPH). We also analysed the anti-inflammatory activity by the human
red blood cell membrane stabilization (HRBC), and the egg albumin assays. Finally, the
cytotoxicity of this preparation was assessed by the MTT assay. When 75mg/ml of sample
preparation was compared to Gallic acid (GA) the total phenolic content was found to be 5mg/g
GA equivalent. The total flavonoid content of 75mg/ml sample was 0.02mg/g Quercetin
equivalent. For the DPPH assay, the highest percentage radical scavenging value was reported to
be 91.79%, at the maximum concentration (75 mg/ml) tested and the IC50 was found as
<3.75mg/ml. The anti-inflammatory activity of the preparation was found to be 46.09%
inhibition of protein denaturation at 75mg/ml sample while Ibuprofen showed a similar
inhibition: 51.30%. The HRBC assay depicted 52.85% inhibition of red cell lysis at 75mg/ml,
while Ibuprofen showed 97.20% inhibition. Finally, a moderate cytotoxic effect was noted in Vero
cells by the MTT assay where a concentration of 10μg/ml depicted a ~35% cell growth inhibition
at 24h. This commercial preparation of Bamboo Swarasa demonstrated excellent antioxidant
activity and moderate anti-inflammatory activity at a concentration of 75mg/ml. Viral infections
are usually accompanied by oxidative stress, which plays an important role in their pathogenesis,
and antioxidants are able to reduce the reactive oxygen species level in infected cells. Thus, this
preparation could be an effective medicine for viral diseases such as dengue. This work provides
only preliminary scientific evidence, and further research will be conducted to determine its
antiviral activity.